cyc 202 has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubel, C; Bourhis, J; Connault, E; Deutsch, E; Haton, C; Maggiorella, L; Milliat, F; Opolon, P | 1 |
| Al-Omran, M; de Nigris, F; Giordano, A; Infante, T; Mancini, FP; Minucci, PB; Napoli, C; Schiano, C; Zullo, A | 1 |
2 other study(ies) available for cyc 202 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma.
Topics: Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Culture Media, Conditioned; DNA Primers; Flow Cytometry; Humans; Immunohistochemistry; Neovascularization, Pathologic; Polymerase Chain Reaction; Purines; Radiation, Ionizing; Roscovitine; Vascular Endothelial Growth Factor A | 2009 |
Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis.
Topics: Animals; Antineoplastic Agents; Aorta; Apoptosis; Bone Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 5; Endothelial Cells; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Osteosarcoma; Purines; Roscovitine; Up-Regulation; YY1 Transcription Factor | 2013 |